A detailed history of Aqr Capital Management LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 21,859 shares of CADL stock, worth $187,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,859
Previous 20,036 9.1%
Holding current value
$187,550
Previous $138,000 36.96%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$3.96 - $9.96 $7,219 - $18,157
1,823 Added 9.1%
21,859 $189,000
Q3 2024

Nov 14, 2024

BUY
$5.02 - $7.76 $100,580 - $155,479
20,036 New
20,036 $138,000

Others Institutions Holding CADL

About Candel Therapeutics, Inc.


  • Ticker CADL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,891,900
  • Market Cap $248M
  • Description
  • Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...
More about CADL
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.